Vigil Neuroscience (VIGL) Institutional Ownership → DON’T buy gold until you read this (From Sasco Gold LLC) (Ad) Free VIGL Stock Alerts $4.40 -0.20 (-4.35%) (As of 06/10/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Vigil Neuroscience (NASDAQ:VIGL)CurrentInstitutional OwnershipPercentage83.64%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$1.16MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$7.20M Get VIGL Insider Trade Alerts Want to know when executives and insiders are buying or selling Vigil Neuroscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VIGL Institutional Buying and Selling by Quarter Ad Sasco Gold LLCDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is for YOU. 99% of people are buying gold the wrong way.Reserve your seat here. Vigil Neuroscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024 Vanguard Group Inc.894,473$3.05M0.0%+11.9%2.380% 1/30/2024 Strs Ohio8,200$27K0.0%N/A0.023% 12/6/2023 Citigroup Inc.64,303$347K0.0%-6.9%0.179% 11/15/2023 Laurion Capital Management LP10,839$58K0.0%-89.1%0.030% 11/14/2023 Deerfield Management Company L.P. Series C1,827,400$9.85M0.2%-10.9%5.093% 11/14/2023 PEAK6 Investments LLC23,796$128K0.0%+66.0%0.066% 8/14/2023 Deep Track Capital LP1,773,409$16.67M0.8%-12.4%4.944% 8/11/2023 Artal Group S.A.1,911,191$17.97M0.6%-14.8%5.328% 8/4/2023 American International Group Inc.7,734$73K0.0%N/A0.022% 8/2/2023 Bank of Montreal Can73,243$728K0.0%N/A0.205% 5/4/2023 Barclays PLC104,248$1.02M0.0%-1.6%0.292% 2/14/2023 683 Capital Management LLC15,092$189K0.0%N/A0.042% 2/13/2023 Artal Group S.A.2,243,352$28.04M1.6%-1.8%6.305% 2/9/2023 Citigroup Inc.93,927$1.17M0.0%+38.8%0.264% 2/1/2023 Bank of Montreal Can58,100$726K0.0%N/A0.163% 11/15/2022 BVF Inc. IL1,813,633$16.50M0.7%N/A5.097% 11/15/2022 Citadel Advisors LLC2,166,467$19.72M0.0%+0.1%6.089% 11/14/2022Ergoteles LLC28,533$260K0.0%N/A0.101% 11/14/2022 Altium Capital Management LP15,788$144K0.1%N/A0.056% 8/15/2022 Laurion Capital Management LP130,200$336K0.0%N/A0.461% 5/16/2022 Deep Track Capital LP389,141$2.74M0.2%N/A1.377% 5/12/2022 Artal Group S.A.1,121,191$7.88M0.3%N/A3.966% 5/5/2022 New York State Common Retirement Fund8,500$60K0.0%N/A0.030% (Data available from 1/1/2016 forward) VIGL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VIGL shares? During the previous two years, 16 institutional investors and hedge funds held shares of Vigil Neuroscience. The most heavily invested institutionals were Citadel Advisors LLC ($19.72M), Artal Group S.A. ($17.97M), Deep Track Capital LP ($16.67M), BVF Inc. IL ($16.50M), Deerfield Management Company L.P. Series C ($9.85M), Vanguard Group Inc. ($3.05M), and Barclays PLC ($1.02M).Learn more on VIGL's institutional investors. What percentage of Vigil Neuroscience stock is owned by institutional investors? 83.64% of Vigil Neuroscience stock is owned by institutional investors. Learn more on VIGL's institutional investor holdings. Which institutional investors have been buying Vigil Neuroscience stock? Of the 12 institutional investors that purchased Vigil Neuroscience stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($1.81M), Bank of Montreal Can ($131.34K), Laurion Capital Management LP ($130.20K), Vanguard Group Inc. ($95.28K), Ergoteles LLC ($28.53K), Citigroup Inc. ($26.27K), and Altium Capital Management LP ($15.79K). How much institutional buying is happening at Vigil Neuroscience? Institutional investors have bought a total of 2,282,961 shares in the last 24 months. This purchase volume represents approximately $19.66M in transactions. Which Vigil Neuroscience major shareholders have been selling company stock? The following institutional investors have sold Vigil Neuroscience stock in the last 24 months: Artal Group S.A. ($374.38K), Deep Track Capital LP ($251.73K), Deerfield Management Company L.P. Series C ($224.61K), Laurion Capital Management LP ($88.85K), Citigroup Inc. ($4.77K), and Barclays PLC ($1.65K). How much institutional selling is happening at Vigil Neuroscience? Institutional investors have sold a total of 945,990 shares in the last 24 months. This volume of shares sold represents approximately $7.75M in transactions. Related Companies: JSPR Institutional Ownership AGEN Institutional Ownership TRML Institutional Ownership AURA Institutional Ownership AVXL Institutional Ownership CCCC Institutional Ownership SOPH Institutional Ownership STRO Institutional Ownership MGTX Institutional Ownership REPL Institutional Ownership This page (NASDAQ:VIGL) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vigil Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vigil Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.